Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Bob L who wrote (3126)	6/2/1999 10:12:00 PM
From: Maurice Winn	Read Replies (3) \| Respond to of 3702

Bob, it isn't really off-topic! Anyway, they can just click right past my name if they like. The IND compassionate use approvals are obviously more bureaucracy than reality if there have been so few individual applications. There is no incentive for doctors to step out from the FDA shroud. They would be using professional judgement and that could lead to being accused of doing things wrong. Better safe, for them, than sorry. I don't blame them for taking such an approach. If course they will hem and haw. They are on safe ground, like all bureaucrats, if they throw the book at the problem and avoid innovation. You know the saying about the pioneer being the one with the arrows in his back. As many people know, the actual paperwork procedure for something might well be trivial, but can appear huge to people unversed in the systems and laws. This is always of great comfort to bureaucrats, lawyers and the like. Any patient in the USA will be well aware that their lives are totally under the control and jurisdiction of the powerful and bureacratic and unless they get on side with one of the powerful brokers they are farting against thunder, to coin a phrase. It takes very little out of the ordinary for a patient or their accomplice [in medical parlance] to appear like a character from Mars. The main tack is to push the patient back into the shape of the 'patient' box. Sometimes that is coffin-shaped. Time and money are of the essence in the world of medicine. I guess it's fair to say that in the long run, we are all dead, so why worry? Because mostly people prefer to defer that day. Patience is a virtue. Patient patients are popular. As the AIDS people found, a bit of impatience can get better patients. Practising doctors should admit that they are practising on impatient patients. Okay, weak puns! Bye, We don't hear much about compassionate use of Oncolym or Cotara do we, even though these products do a good job of killing cancer cells by the trillion with negligible harm to people. Few patients would know that they could apply to TCLN for Treatment IND because their oncologists won't tell them and won't support them until the FDA rule book is happy. Maurice